HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Immune Health Vitamins And Minerals Drove German Supplement Market Growth In 2021

Executive Summary

Double-digit increases in sales of omega 3 supplements, vitamin A and D combinations and single product B vitamins helped Germany's dietary supplements market grow by 2.1% to €2.7bn in 2021, according to IQVIA Commercial. 

You may also be interested in...



Researchers Suggest 3 Grams Omega-3s Daily Optimal, But Don't Back Allowing Health Claim

A meta-analysis of studies comprising almost 5,000 participants showed a promising link between a 3-gram daily dose of omega-3s and lower blood pressure in adults with and without high blood pressure.

AESGP Annual Meeting, Day 2 (Part 1): The Future For Europe’s Self-Care Industry Is Bright And Digital

Day 2 of the AESGP’s 58th Annual Meeting in Madrid, Spain begins with optimism about the future of the European self-care industry. Google and IQVIA Consumer Health analyze COVID-19 trends to help industry prepare for the post-pandemic new normal, while Convert Group and Swedish e-pharmacy Meds.se emphasize the opportunity presented by e-commerce for consumer health.

'Tectonic' Shifts In Germany’s OTC Market Require Smart Sales Strategies

Data from Sempora Consulting shows Germany's OTC market is still struggling to return to pre-pandemic growth levels in the first quarter of 2022. Digging deeper into recent trends like e-commerce and inflationary pricing, the firm suggests a number of points for consumer healthcare companies to consider in formulating their sales strategies for the rest of the year.

Related Content

Topics

Latest News
UsernamePublicRestriction

Register

RS152519

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel